Medical reagents
Ended Awarded Last action
- Contract number
- HT942524F0051
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $46,635
Award facts
- Contract value 100% obligated
- $46,635.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- JBSA FT SAM HOUSTON, TX 78234, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $46,635 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) on May 4, 2022, for the procurement of medical reagents to support research operations at JBSA Fort Sam Houston, Texas. This award represents a task order issued under Harvard Bioscience's single-award Blanket Purchase Agreement with the Defense Health Agency, valued at $4.8 million and effective through May 3, 2027. The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency, Army Medical Command, and other military health system partners to streamline procurement of specialized biomedical research solutions, including telemetry equipment, surgical supplies, data acquisition systems, and research consumables. No set-aside designation was applied to this particular call order.
Harvard Bioscience Inc., a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in developing and manufacturing advanced physiological monitoring technologies and biomedical research equipment for federal agencies. The company's expertise encompasses wireless implantable telemetry transmitters, respiratory monitoring systems, data acquisition software, and related research instrumentation used in preclinical studies. Under the underlying BPA, Harvard Bioscience has generated over $1.5 million in cumulative procurement value through task orders ranging from approximately $8,320 to $235,556, demonstrating the strategic importance of its specialized biomedical solutions to defense and military health sector research initiatives.
Quick answers
Who was awarded contract HT942524F0051?
HT942524F0051 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on May 4, 2022.
How much is contract HT942524F0051 worth?
The government has obligated $46,635 on HT942524F0051.
Is contract HT942524F0051 an order under another contract?
Yes. HT942524F0051 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942524F0051 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award